Malignant Head and Neck Mucosal Neoplasm

Malignant Head and Neck Mucosal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 80
Ph III recruiting: 9
Growth YoY: +33.3%
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (63)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04576091	Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer	active not recruiting	Phase 1	7	National Cancer Institute (NCI)NIH	1	Aug 21, 2026	clinicaltrials
NCT00336063	Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma	active not recruiting	Phase 1	18	National Cancer Institute (NCI)NIH	4	Aug 19, 2026